Amgen
RIABNI
Manufacturer:
Amgen
Name:
RIABNI
HCPCS Code Descriptor:
Injection, rituximab-arrx, biosimilar, (riabni), 10 mg
Category:
Q Code
HCPCS:
Q5123
NDC(s):
55513-0326-01, 55513-0224-01
Primary Type:
Oncology Biosimilar
Generic Status:
Single-Source
Route of Administration:
Intravenous
About:
RIABNI is an Oncology Biosimilar drug manufactured by Amgen and administered via the Intravenous route of administration. The Q Code: Q5123 is aligned to the drug RIABNI.
Riabni is a biosimilar for the reference drug Avastin (J9035)
Access Pricing and More By Registering
HCPCS Added Date:
7/1/21
HCPCS Effective Date:
7/1/21
HCPCS Short Description:
Inj. riabni, 10 mg
Billing and Coding Guide:
https://www.riabni.com/oncology/-/media/Themes/Amgen/riabni/Riabni/PDF/RIABNI-Product-Resource-Guide
Patient Assistance:
https://www.amgenassist.com/copay
http://www.amgensafetynetfoundation.com